EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results

Valeria Fedeli, Angela Catizone iD, Alessandro Querqui, Vittorio Unfer iD, Mariano Bizzarri iD

International Journal of Molecular Sciences · 27.03.2023 · 24 (7) · 6296

DOI: 10.3390/ijms24076296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2023. Verfasst von Valeria Fedeli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, University La Sapienza, Via A. Scarpa 16, 00160 Rome, Italy. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Hyperandrogenism, Insulin Resistance. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovarian syndrome (PCOS) is the most common endocrinological disorder in women, in which, besides chronic anovulation/oligomenorrhea and ovarian cysts, hyperandrogenism plays a critical role in a large fraction of subjects. Inositol isomers—myo-Inositol and D-Chiro-Inositol—have recently been pharmacologically effective in managing many PCOS symptoms while rescuing ovarian fertility. However, some disappointing clinical results prompted the reconsideration of their specific biological functions. Surprisingly, D-Chiro-Ins stimulates androgen synthesis and decreases the ovarian estrogen pathway; on the contrary, myo-Ins activates FSH response and aromatase activity, finally mitigating ovarian hyperandrogenism. However, when the two isomers are given in association—according to the physiological ratio of 40:1—patients could benefit from myo-Ins enhanced FSH and estrogen responsiveness, while taking advantage of the insulin-sensitizing effects displayed mostly by D-Chiro-Ins. We need not postulate insulin resistance to explain PCOS pathogenesis, given that insulin hypersensitivity is likely a shared feature of PCOS ovaries. Indeed, even in the presence of physiological insulin stimulation, the PCOS ovary synthesizes D-Chiro-Ins four times more than that measured in control theca cells. The increased D-Chiro-Ins within the ovary is detrimental in preserving steroidogenic control, and this failure can easily explain why treatment strategies based upon high D-Chiro-Ins have been recognized as poorly effective. Within this perspective, two factors emerge as major determinants in PCOS: hyperandrogenism and reduced aromatase expression. Therefore, PCOS could no longer be considered a disease only due to increased androgen synthesis without considering the contemporary downregulation of aromatase and FSH receptors. Furthermore, these findings suggest that inositols can be specifically effective only for those PCOS phenotypes featured by hyperandrogenism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeHyperandrogenismInsulin ResistanceHumansFemaleInositolAromataseAndrogensInsulinFollicle Stimulating HormoneEstrogens

Stichwörter der Autor:innen

D-Chiro-inositolepimerasehyperandrogenisminsulin resistancemyo-inositolpolycystic ovary syndrome

Substanzen

InositolAromataseAndrogensInsulinFollicle Stimulating HormoneEstrogens

Autor:innen und Institutionen

  • Department of Experimental Medicine, University La Sapienza, Via A. Scarpa 16, 00160 Rome, Italy.
  • Section of Histology and Embryology, Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Sapienza University of Rome, Via A. Scarpa 16, 00160 Rome, Italy.
  • Systems Biology Group Lab, University La Sapienza, 00185 Rome, Italy.
  • The Experts Group on Inositol in Basic and Clinical Research (EGOI), 00161 Rome, Italy.
  • AGUNCO Obstetrics & Gynecology Center, UniCamillus-Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy.

ORCID-Profile: Angela Catizone, Vittorio Unfer, Mariano Bizzarri

Zitieren

APA

Fedeli, V., Catizone, A., Querqui, A., Unfer, V., & Bizzarri, M. (2023). The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results. International Journal of Molecular Sciences, 24(7), 6296. https://doi.org/10.3390/ijms24076296

Vancouver

Fedeli V, Catizone A, Querqui A, Unfer V, Bizzarri M. The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results. International Journal of Molecular Sciences. 2023;24(7):6296. doi:10.3390/ijms24076296

BibTeX
@article{Fedeli2023,
  author = {Fedeli, Valeria and Catizone, Angela and Querqui, Alessandro and Unfer, Vittorio and Bizzarri, Mariano},
  title = {The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {7},
  pages = {6296},
  doi = {10.3390/ijms24076296}
}
Kostenlos starten →